Literature DB >> 21618575

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.

Ruben Hernaez1,2,3, Mariana Lazo1, Susanne Bonekamp4, Ihab Kamel4, Frederick L Brancati1,3,5, Eliseo Guallar3,5,6, Jeanne M Clark1,3,5.   

Abstract

UNLABELLED: Ultrasonography is a widely accessible imaging technique for the detection of fatty liver, but the reported accuracy and reliability have been inconsistent across studies. We aimed to perform a systematic review and meta-analysis of the diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver. We used MEDLINE and Embase from October 1967 to March 2010. Studies that provided cross-tabulations of ultrasonography versus histology or standard imaging techniques, or that provided reliability data for ultrasonography, were included. Study variables were independently abstracted by three reviewers and double checked by one reviewer. Forty-nine (4720 participants) studies were included for the meta-analysis of diagnostic accuracy. The overall sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of ultrasound for the detection of moderate-severe fatty liver, compared to histology (gold standard), were 84.8% (95% confidence interval: 79.5-88.9), 93.6% (87.2-97.0), 13.3 (6.4-27.6), and 0.16 (0.12-0.22), respectively. The area under the summary receiving operating characteristics curve was 0.93 (0.91-0.95). Reliability of ultrasound for the detection of fatty liver showed kappa statistics ranging from 0.54 to 0.92 for intrarater reliability and from 0.44 to 1.00 for interrater reliability. Sensitivity and specificity of ultrasound was similar to that of other imaging techniques (i.e., computed tomography or magnetic resonance imaging). Statistical heterogeneity was present even after stratification for multiple clinically relevant characteristics.
CONCLUSION: Ultrasonography allows for reliable and accurate detection of moderate-severe fatty liver, compared to histology. Because of its low cost, safety, and accessibility, ultrasound is likely the imaging technique of choice for screening for fatty liver in clinical and population settings.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21618575      PMCID: PMC4197002          DOI: 10.1002/hep.24452

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  69 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.

Authors:  Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

3.  Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.

Authors:  Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp-Arida; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel E Lavine; Naga Chalasani; Kris V Kowdley
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

4.  [Diagnosis of fatty liver--comparison of ultrasonographic and computed tomographic findings to histological features].

Authors:  S Saitoh; T Nagamine; H Takagi; T Sekiguchi; M Uehara; K Yuasa; S Saeki; H Takahashi; T Arai; J Takezawa
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1988-12

5.  [Diagnostic value of the hepatic echo-histogram in chronic hepatopathy].

Authors:  G Castellano; A González; F Colina; S Rodríguez; M T Muñoz; F Sánchez; C Garfia; B Casis; I Fernández; F Canga
Journal:  Rev Esp Enferm Dig       Date:  1993-12       Impact factor: 2.086

6.  [Importance of ultrasonography in the diagnosis of diffuse parenchymal disorders of the liver].

Authors:  M Pirovino; W Grauer; A Götz; M Huber; J Altorfer; E Maranta; M Schmid
Journal:  Schweiz Med Wochenschr       Date:  1982-04-12

7.  Is ultrasonography useful in the assessment of diffuse parenchymal liver disease?

Authors:  N L Sanford; P Walsh; C Matis; H Baddeley; L W Powell
Journal:  Gastroenterology       Date:  1985-07       Impact factor: 22.682

8.  Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.

Authors:  Mariana Lazo; Steven F Solga; Alena Horska; Susanne Bonekamp; Anna Mae Diehl; Frederick L Brancati; Lynne E Wagenknecht; F Xavier Pi-Sunyer; Steven E Kahn; Jeanne M Clark
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

9.  [Utility of liver biopsy in the etiologic diagnosis of biochemical liver abnormalities of unknown cause].

Authors:  Irina Salueña; Luis Ortega; María J Devesa; Gustavo López-Alonso; Carlos Taxonera; Manuel Díaz-Rubio; José M Ladero
Journal:  Gastroenterol Hepatol       Date:  2007 Jun-Jul       Impact factor: 2.102

10.  Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy.

Authors:  Mireille A Edens; Peter M A van Ooijen; Wendy J Post; Mark J F Haagmans; Wisnumurti Kristanto; Paul E Sijens; Erik J van der Jagt; Ronald P Stolk
Journal:  Obesity (Silver Spring)       Date:  2009-05-21       Impact factor: 5.002

View more
  374 in total

1.  Sonographic Features of the Liver Among Females with Type 2 Diabetes.

Authors:  Bárbara L Riestra-Candelaria; Loida A González-Rodríguez; Wilma Rodriguez-Mojica; Luis E Vázquez-Quiñones; Juan Carlos Jorge
Journal:  J Diagn Med Sonogr       Date:  2019-03-08

Review 2.  Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.

Authors:  Mazen Noureddin; José M Mato; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-13

3.  Heme oxygenase-1 gene promoter polymorphism and the risk of pediatric nonalcoholic fatty liver disease.

Authors:  P-F Chang; Y-C Lin; K Liu; S-J Yeh; Y-H Ni
Journal:  Int J Obes (Lond)       Date:  2015-04-03       Impact factor: 5.095

4.  Sonographic assessment of fatty liver: intraobserver and interobserver variability.

Authors:  Mustafa Cengiz; Senem Sentürk; Bulent Cetin; Aylin Hasanefendioğlu Bayrak; Senem Uysal Bilek
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 5.  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.

Authors:  A L L Rocha; L C Faria; T C M Guimarães; G V Moreira; A L Cândido; C A Couto; F M Reis
Journal:  J Endocrinol Invest       Date:  2017-06-13       Impact factor: 4.256

6.  Nonalcoholic fatty liver disease is associated with cognitive function in adults.

Authors:  Sang Won Seo; Rebecca F Gottesman; Jeanne M Clark; Ruben Hernaez; Yoosoo Chang; Changsoo Kim; Kyoung Hwa Ha; Eliseo Guallar; Mariana Lazo
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

7.  Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.

Authors:  Surya Prakash Bhatt; Randeep Guleria; Naval K Vikram; A K Gupta
Journal:  Sleep Breath       Date:  2018-07-22       Impact factor: 2.816

8.  Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing.

Authors:  Joseph S Redman; Yamini Natarajan; Jason K Hou; Jingqi Wang; Muzammil Hanif; Hua Feng; Jennifer R Kramer; Roxanne Desiderio; Hua Xu; Hashem B El-Serag; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2017-08-31       Impact factor: 3.199

Review 9.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

10.  Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.

Authors:  Shira Zelber-Sagi; Muriel Webb; Nimer Assy; Laurie Blendis; Hanny Yeshua; Moshe Leshno; Vlad Ratziu; Zamir Halpern; Ran Oren; Erwin Santo
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.